Back
Brainstorm Cell Therapeutics Vs. RH Industry Stock Comparison
Sell
29
BCLI
Brainstorm Cell Therapeutics
Last Price:
0.39
Seasonality Move:
18.66%
Sell
27
RH
RH
Last Price:
215.00
Seasonality Move:
8.36%
Sell
29
Brainstorm Cell Therapeutics (BCLI)
is a Sell
Is Brainstorm Cell Therapeutics a Buy, Sell or Hold?
- The current Brainstorm Cell Therapeutics [BCLI] share price is $0.38. The Score for BCLI is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- BCLI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
RH (RH)
is a Sell
Is RH a Buy, Sell or Hold?
- The current RH [RH] share price is $223.28. The Score for RH is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- RH is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BCLI Stock Price Chart
What is Brainstorm Cell Therapeutics's stock price today?
-
The Brainstorm Cell Therapeutics share price today is $0.38
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCLI is experiencing slight selling pressure.
RH Stock Price Chart
BCLI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 38.27 | Sell |
| Chaikin Money Flow: | -94334 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.4 - 0.54) | Sell |
| Bollinger Bands (100): | (0.35 - 0.57) | Sell |
RH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -12.65 | Sell |
| Relative Strength Index (14 RSI): | 35.6 | Sell |
| Chaikin Money Flow: | -130480 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (235.98 - 280.62) | Sell |
| Bollinger Bands (100): | (246.94 - 291.42) | Sell |
BCLI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.42 | Sell |
| 20-day SMA: | 0.45 | Sell |
| 50-day SMA: | 0.48 | Sell |
| 200-day SMA: | 0.4 | Sell |
| 8-day EMA: | 0.41 | Sell |
| 20-day EMA: | 0.44 | Sell |
| 50-day EMA: | 0.47 | Sell |
| 200-day EMA: | 0.67 | Sell |
RH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 237.67 | Sell |
| 20-day SMA: | 256.11 | Sell |
| 50-day SMA: | 260.98 | Sell |
| 200-day SMA: | 267.35 | Sell |
| 8-day EMA: | 233.82 | Sell |
| 20-day EMA: | 250.28 | Sell |
| 50-day EMA: | 261.55 | Sell |
| 200-day EMA: | 273.68 | Sell |
Brainstorm Cell Therapeutics Earnings Growth & BCLI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and an increase next year of $0.02 per share.
RH Earnings Growth & RH Earnings Dates
- Analysts estimate an earnings decrease this quarter of $2.20 per share, an increase next quarter of $0.47 per share, a decrease this year of $16.71 per share, and a decrease next year of $0.15 per share.
Brainstorm Cell Therapeutics Technical Analysis
| Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
RH Technical Analysis
| Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||